相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The miR-371 similar to 373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis
Pit Ullmann et al.
CANCER RESEARCH (2018)
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Benjamin L. Bryson et al.
CELL CYCLE (2017)
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma
Nisebita Sahu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
D. J. Junk et al.
ONCOGENE (2017)
TNFα and TGFβ-1 synergistically increase the cancer stem cell properties of MiaPaCa-2 cells
Aikyn Kali et al.
ONCOLOGY LETTERS (2017)
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar et al.
CANCERS (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells
Yuan Seng Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
Susann Busch et al.
CANCER RESEARCH (2015)
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
Nagaraj S. Nagathihalli et al.
GASTROENTEROLOGY (2015)
miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer (vol 10, e0130194, 2015)
Jialu Li et al.
PLOS ONE (2015)
Neutralizing Murine TGFβR2 Promotes a Differentiated Tumor Cell Phenotype and Inhibits Pancreatic Cancer Metastasis
Katherine T. Ostapoff et al.
CANCER RESEARCH (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
TGF-β: Duality of Function Between Tumor Prevention and Carcinogenesis
Daniel R. Principe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Erlotinib Prolongs Survival in Pancreatic Cancer by Blocking Gemcitabine-Induced MAPK Signals
Koji Miyabayashi et al.
CANCER RESEARCH (2013)
Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer
Kolaparthi Venkatasubbarao et al.
MOLECULAR CANCER (2013)
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
N. Skrypek et al.
ONCOGENE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways
Nicolas Jonckheere et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Comprehensive Genomic Analysis of a BRCA2 Deficient Human Pancreatic Cancer
Louise J. Barber et al.
PLOS ONE (2011)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
Angeliki Voulgari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression
N. Jonckheere et al.
BRITISH JOURNAL OF CANCER (2009)
Mechanisms of the epithelial-mesenchymal transition by TGF-beta
Michael K. Wendt et al.
FUTURE ONCOLOGY (2009)
Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation
Haiyan R. Qin et al.
CANCER RESEARCH (2008)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1α
Guillaume Piessen et al.
BIOCHEMICAL JOURNAL (2007)
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression
Hideaki Ijichi et al.
GENES & DEVELOPMENT (2006)
The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells
M van der Sluis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-β in pancreatic carcinogenesis
N Jonckheere et al.
ONCOGENE (2004)
Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines
P Mesquita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
分享论文
